baber/WOPTO huggingface dataset:
Patent NZ-193813-A (NZ)
Title: A process for a substituted propan-2-ol 3-nitro-1-phenyl-1-(m-chlorophenyl) propan-2-ol
Inventor: SMITH P
IPC: C07C215/28
Filed: 1980-05-22
Abstract: A process for the preparation of 3-dimethylamino-1-phenyl- (m-chlorophenyl)propan-2-ol and its salts which comprises the reaction of m-chlorophenyl-phenyl-acetaldehyde with nitromethane to yield 3-nitro-1-phenyl-1-(m-chlorophenyl) propan-2-ol followed by the Raney nickel catalysed reduction of this compound with simultaneous or subsequent dimethylation and thereafter, if desired, salification.
Patent NZ-198627-A (NZ)
Title: Single use typewriter ribbon cartridge with frangible resistive element for restraining takeup spool growth
Inventor: CRAFT J A
IPC: B41J33/26
Filed: 1981-10-13
Abstract: In ribbon cartridges (10) including a ribbon take-up spool (20) which is peripherally driven by a spacially fixed driving roller (18), it is necessary for the take-up spool (20) to move away from the driving roller (18), as the ribbon (22) accumulates on the spool (20), while remaining in proper driving engagement with the roller (18). According to the invention, this is achieved by a frangible member (24) which resists the movement of the take-up spool axle (28) except when caused by ribbon accumulation. Frangible member (24) may either be formed as an integral part of the cartridge walls or be bonded thereto. Member (24) will break or tear as axle (28) is forced away from roller (18) by the increasing diameter of take-up spool (20).
Patent NZ-205718-A (NZ)
Title: Mineral particle slurry and method of treating aqueous systems therewith
Inventor: BECKETT C A
IPC: C02F1/52
Filed: 1983-09-23
Abstract: An aqueous slurry of mineral particles, for example calcium carbonate and/or calcium hydroxide, has a mineral solids concentration of at least 40% m/m and contains an agent that maintains the slurry at a pumpable viscosity but that acts as a flocculant upon dilution of the slurry. Suitable agents include cationic and amphoteric polyelectrolytes having nitrogen-containing groups, for example polyamines and dimethyl diallyl ammonium chloride polymers. The slurries may contain other components for example a synthetic hectorite or a dispersing agent such as a polyacrylate, polymethacrylate or polyphosphate. The slurries are useful in papermaking and in the treatment of sewage.
Patent NZ-212701-A (NZ)
Title: Pick-up hay harvester with quickly detachable cutters in conveyor duct
Inventor: STEFFENS JOSEF
IPC: A01D90/04
Filed: 1985-07-10
Abstract: 1. A cutter mechanism for stalk crop materials comprising a plurality of blades (6) which are arranged releasably in a conveyor passage (7) of a harvester and which are mounted pivotably about a respective pivot axis (9) fixed to the wall of the conveyor passage (7) and which are held in the operative position by a respective pin (12), the pin being connected to the upper end of a spring (13) and being supported in a depression (17) provided on the rear side of each blade (6) which is in opposite relationship to the pivot axis (9), wherein the lower end of the spring (13), adjacent to the pivot axis (9), is connected to a further pin (23), the blades (6) being pivotable at least partially out of the conveyor passage (7) against the force of the spring (13) upon co-operating with stones or the like foreign bodies, characterised in that the pin (12) which is connected to the upper end of the spring (13) is mounted slidably in a slot (20) in the support structure of the harvester and that the pin (23) which is connected to the lower end of the spring (13) lies positively in a recess (26) in the blade (6) and separably from the blade (6).
Patent NZ-244867-A (NZ)
Title: Packaging material containing a hydrophobic zeolite to reduce transfer of substances from package to contents
Inventor: LINDGREN ERIK
IPC: C01B39/24
Filed: 1992-10-23
Abstract: The present invention relates to a packaging material for reduced transfer from a package to its content of substances causing undesirable taste and/or hazardous substances, this reduction being due to the packaging material containing a hydrophobic zeolite. More specifically, the invention concerns paperboard, in which case the substances causing undesirable taste mainly are naturally occurring extractive substances, oxidation products thereof and, to a lesser extent, the paper chemicals present. Further, the presence of a hydrophobic zeolite in the paperboard enhances the water-repellent (hydrophobic) capacity. Also, the present invention concerns a method for production of a packaging material of paper, board or paperboard by forming and dewatering a suspension of lignocellulose-containing fibres, where the dewatering takes place in the presence of a hydrophobic zeolite. Moreover, the present invention relates to the use of a hydrophobic zeolite for production of a packaging material, as well as the use of the thus-produced packaging material in packages for solid or liquid foodstuff, tobacco or medicines.
Patent NZ-254014-A (NZ)
Title: Hybrid maize seeds with high amylose content; high amylose starch
Inventor: MCNAUGHT KENNETH
IPC: A23L1/0522
Filed: 1993-07-30
Abstract: Hybrid maize seeds which yield a starch having an amylose content of 80 % or more are disclosed as are starches having that amylose content. Compositions including these high amylose starches are also disclosed. Fractions of high amylose starches which have been formed on the basis of granule size are shown to have enhanced dietary fibre and/or resistant starch content. Such fractions enable the preparation of food compositions of enhanced dietary fibre and/or resistant starch content.
Patent NZ-260109-A (NZ)
Title: One-part aqueous adhesive composition comprising vinyl ester/ethylene copolymer containing a carboxylic acid monomer (neutralised); construction laminates
Inventor: EISENHART ERIC KARL
IPC: C09J125/02
Filed: 1994-03-16
Abstract: A composition, particularly suitable for use as a one-part aqueous laminating construction adhesive composition, comprising an adhesive copolymer consisting essentially of a vinyl ester/ethylene copolymer comprising a copolymerized carboxylic acid monomer, said vinyl ester/ethylene copolymer having a glass transition temperature from 0 DEG C to about - 15 DEG C, wherein said copolymerized carboxylic acid is neutralized with from 1% to 10% of a nonvolatile base, by weight based on said vinyl ester/ethylene copolymer weight. A method for producing the composition is also provided.
Patent NZ-261259-A (NZ)
Title: Humanised recombinant anti-vla4 antibody and diagnostic compositions and medicaments
Inventor: LOBB ROY RICHARD
IPC: C07K19/00
Filed: 1994-01-07
Abstract: The present invention disclosed recombinant anti-VLA-4 antibody molecules, including humanized recombinant anti-VLA-4 antibody molecules. These antibodies are useful in the treatment of specific and non-specific inflammation, including asthma and inflammatory bowel disease. In addition, the humanized recombinant anti-VLA-4 antibodies disclosed can be useful in methods of diagnosing and localizing sites of inflammation.
Patent NZ-263664-A (NZ)
Title: Extrusion laminate of non-woven fibrous web and thermoplastic film formed by incremental stretching of web and compressing web against film
Inventor: WU PAI-CHUAN
IPC: B32B27/12
Filed: 1994-03-09
Abstract: Extrusion laminates of incrementally stretched nonwoven fibrous webs and thermoplastic films are made. A web of spun bonded fibers is incrementally stretched to provide fiber ends extending outwardly from both web surfaces for bonding with the extruded thermoplastic film and to provide a soft fibrous texture to the laminate.
Patent NZ-272014-A (NZ)
Title: Transdermal administration composition: active lipophilic agent plus silicon based adhesive polymer, absorption promoter and volatile solvent
Inventor: LAURENT PHILIPPE
IPC: A61K9/70
Filed: 1995-04-28
Abstract: Compsn. designed to form a film on the skin for transdermal admin. of an active agent, comprises: a) a lipophilic active agent, b) 5-60 wt.% of a silicone-based adhesive polymer compsn. c) 0-25 wt.% of an absorption promoter, and d) 25-95 wt.% of a volatile solvent.
Patent NZ-281866-A (NZ)
Title: Epoxide synthesis of condensed 1,3-oxazoles
Inventor: ASKIN DAVID
IPC: C07D413/04
Filed: 1995-02-27
Abstract: A process for synthesizing the epoxide of formula (I) consists of, at a minimum, formation of a halohydrin form the allyl acetonide reactant, followed by base-induced cyclization, the epoxide product (I) being useful as an intermediate for the synthesis of inhibitors of renin or HIV protease or other proteases.
Patent NZ-311091-A (NZ)
Title: Diagnostic test comprising recombinant dna and polypeptides for use in vaccines for equine arteritis virus (eav) and eav mediated disease
Inventor: CHIRNSIDE EWAN DOUGLAS
IPC: C07K14/165
Filed: 1996-06-20
Abstract: PCT No. PCT/GB96/01505 Sec. 371 Date Feb. 19, 1998 Sec. 102(e) Date Feb. 19, 1998 PCT Filed Jun. 20, 1996 PCT Pub. No. WO97/00963 PCT Pub. Date Jan. 9, 1997This invention relates to recombinant DNA and polypeptides encoded thereby which have use in the provision of vaccines, diagnostic test kits and methods of diagnosis and treatment or prophylaxis for equine arteritis virus (EAV) and EAV mediated disease.
Patent NZ-318915-A (NZ)
Title: Inhalation device
Inventor: BERG ELNA
IPC: A61M15/00
Filed: 1996-09-23
Abstract: An inhalation device for use with an inhaler 7 for providing a dose of a substance includes a section for receiving the inhaler within the device, a dispersion chamber 3 of substantially   constant volume in fluid connection with the inhaler receiving section, and a suction chamber  2 of variable internal volume in fluid connection with the dispersion chamber.  A negative pressure is generated in the constant volume dispersion chamber as the volume in the suction chamber is increased whereby the substance is moved from said inhaler into the dispersion chamber for subsequent inhalation.
Patent NZ-335599-A (NZ)
Title: Apparatus and method for cleaning poultry
Inventor: MOSTOLLER CHARLES R
IPC: B05B13/02
Filed: 1997-11-13
Abstract: An apparatus is provided for cleaning poultry carcasses (20) having a cavity. A plurality of cleaning heads (80) are spaced about a sprayer carousel (50) that is rotatably mounted upon a vertical shaft (15). The cleaning heads are mounted upon a plurality of vertically oriented guide rails (54) which are spaced about the sprayer carousel. A circumferential cam (70) is fixedly connected to the vertical shaft inside the sprayer carousel. A cam follower connected to each cleaning head follows the profile of the cam, displacing the cleaning head vertically along the guide rails. A conveyor transports the carcasses sequentially into and out of engagement with the sprayer carousel and an indexing member (58) maintains each of the carcasses in alignment with one of the cleaning heads. In response to relative movement between the fixed cam and the rotatable sprayer carousel the cam follower of each cleaning head follows the circumferential profile of the cam. In this way each cleaning head is inserted into the internal cavity of the carcass where the probe is maintained for a dwell period before being withdrawn from the internal cavity.
Patent NZ-337145-A (NZ)
Title: Touch screen overlay apparatus
Inventor: MURPHY PAUL A
IPC: G06F3/0488
Filed: 1999-08-09
Abstract: Overlay apparatus 100 has flexible membrane 101 and frame 102. In use it is removably located in a predetermined position to be superimposed over indicia of a touch screen 20 (typically of a mobile telephone). The overlay is attached to the touch screen by ridges on the overlay engaging grooves on the touch screen in sliding relationship (not shown).
Patent NZ-502707-A (NZ)
Title: Systems utilising optic fibres for steering a catheter through body tissue
Inventor: WINSTON THOMAS R
IPC: A61B18/20
Filed: 1998-07-08
Abstract: Catheters for photoablating plaque build-up in blood vessels are described.  The catheter described herein includes a catheter body having a first group of optic fibers and a second group of optic fibers. The first group of optic fibers is adjacent the second group of optic fibers, and each group of optic fibers includes at least one optic fiber having a first end and a second end. The second ends of the respective optic fibers form a substantially rounded hemispherical catheter head. A control element is coupled to the catheter body and is configured to selectively transmit energy through either the first group of optic fibers, or the second group of optic fibers, or both the first and second groups of optic fibers.
Patent NZ-505814-A (NZ)
Title: A panel fixing system
Inventor: ADDERTON DAVID JOHN
IPC: E04H17/16
Filed: 1999-01-14
Abstract: A panel support assembly (25) comprises a post (10) having at least one elongate recess (12), rotatably supporting a respective panel receiving member (13).  The panel receiving member (13) comprising a rod-like member having an internal channel (14) adapted to receive a panel (11).  The recess (12) is arcuate and respective panel receiving member (13) is cylindrical, partially fitting within recess (12), so as to allow relative rotation.  A pair of panel support assemblies (25), with pairs of panel receiving members (13) facing each other, provides a panel fixing system for fixing a panel (11).
Patent NZ-505955-A (NZ)
Title: Variants of the angiogenic factor vascular endothelial cell growth factor: VEGF-A, and pharmaceutical use
Inventor: BAIRD ANDREW
IPC: C07K14/52
Filed: 1999-02-04
Abstract: Various forms of vascular endothelial growth factor genes and the proteins encoded by these genes are disclosed. More particularly, forms of human VEGF-A which contain exon 6b and do not contain exon 6a are disclosed, these forms of VEGF-A include VEGF-A138, VEGF-A162, and VEGF-A182. VEGF-A138 is the preferred form comprising exons 1-5, 6b and 8. Such VEGF isoforms may be used in treatment of cardiovascular diseases through effects on anatomy, conduit function, and permeability, and more particularly in the treatment of cardiovascular disease by stimulating vascular cell proliferation using a growth factor, thereby stimulating endothelial cell growth and vascular permeability. Also described are nucleic acids encoding the VEGF proteins, and vectors and cells, containing such nucleic acids. The polynucleotides can be used in the treatment of the cardiovascular diseases wherein the polynucleotides are coated onto an inflatable balloon catheter, and for enhancing drug permeation by tumors.
Patent NZ-507427-A (NZ)
Title: Method for preparing alkali metal silicates for glass-making using submerged burners and enriched oxygen
Inventor: JEANVOINE PIERRE
IPC: C01B33/32
Filed: 2000-02-02
Abstract: A process for mmanufacturing compounds based on one or more silicates of alkali metals and/or alkaline-earth metals and/or rare earth metals, optionally in the form of mixed silicates which combine at least two of these elements, comprises the conversion of silica and of halides, or of sulphates or nitrates, of the alkali metal, rare earth metal or alkaline earth metals, wherein the heat necessary for the conversion is supplied at least partially by one pr more submerged burners. The process can be used for preparing vitrifiable batch materials for the manufacture of glass, for preparing raw materials for the manufacture of detergents, or precipitated silica, for the vitrifying/inerting waste of the organochloride-containing0type waste and for retreating sand polluted by fuel oil or other hydrocarbon compounds.. An apparatus for carrying out the process comprises at least one reactor equipped with one or more submerged burners and at least one means for introducing silica and/or the halides, sulphates or nitrates and optionally the solid or liquid fuels, below the level of the materials undergoing melting.
Patent NZ-508766-A (NZ)
Title: A food composition comprising omega-3 and omega-6 polyunsaturated fatty acids and arginine for reducing the damaging effects of radiation therapy on animal skin and mucosa
Inventor: DAVENPORT DEBORAH J
IPC: A23K1/18
Filed: 1999-06-24
Abstract: The severity of damage caused to the skin and mucosa of animals with cancer undergoing radiation therapy is mitigated by feeding the animal a nutritionally balanced food composition containing omega-6 polyunsaturated fatty acids which are supplemented with a mixture of an omega-3 polyunsaturated fatty acids and arginine.  The omega-6:omega-3 ratio is ratio is from about 0.3:1 to 3.5:1 and the arginine is present at a concentration of about 2.0-3.5% on a dry weight basis.
Patent NZ-512218-A (NZ)
Title: Container for dispensing fluid, comprising a pressure control device with activation step
Inventor: VLOOSWIJK JOHANNES JACOBUS THO
IPC: B65D83/36
Filed: 1999-12-14
Abstract: A container with pressure device for maintaining a substantially constant, pre-set pressure in the container, which is arranged for dispensing a fluid. The pressure control device comprises a first chamber for containing a pressure fluid, in particular a pressure gas, a second chamber in which, at least during use, a control pressure prevails, and a third chamber which is formed by or is in communication with, at any rate is at least partly included in an inner space of the container. A control means is movable by a displaceable or deformable part of the wall of the second chamber and is arranged for at least partly displacing the closing member when the pressure in the third chamber is lower than the control pressure, such that the pressure fluid can flow under pressure from the first chamber to the third chamber
Patent NZ-518403-A (NZ)
Title: Remote display of exceptions for document processing system
IPC: G06K17/00
Filed: 2002-04-16
Abstract: A document processing system comprising a document transport (102), a transport controller (110) for directing the operation of the document transport, a transmitter interface (116) for receiving operator messages from the transport controller and wirelessly transmitting the messages through an antenna (117) using omnidirectional RF communication, and an operator display unit (118) for wirelessly receiving operator display messages from the transmitter interface and visually displaying the messages for an operator. An operator audio message unit allows the operator to receive audio messages wherein the transmitter interface (116) is operative to create and transmit the audio messages. Upon detection of an exception document processing is suspended, an operator message is wirelessly transmitted to an operator display unit for visual display describing the exception, and a notification is received when the exception has been cleared.
Patent NZ-520217-A (NZ)
Title: Apparatus and method for distributing content
Inventor: WATANABE YUKO
IPC: G06Q10/00
Filed: 2001-12-05
Abstract: A content delivery method comprises the steps of: Receiving from a network at a first communication terminal a Web page containing storage location information, the storage location information indicating the location content in the network, loading the storage location information into an email, transmitting the email to a second communication terminal, receiving and storing the email at the second communication terminal and opening the email at the second terminal, wherein upon opening the email, content from the network indicated by the storage location information is automatically accessed.
Patent NZ-525030-A (NZ)
Title: Stabilizer ring for a sea anchor
Inventor: FIORENTINO JENERO
IPC: B63B21/48
Filed: 2001-09-12
Abstract: The present invention is a stabilizer ring for a sea anchor, in particular a parachute sea anchor. The preferred embodiment to the stabilizer ring comprises a ring supporting a domed arch. The domed arch has two arch supports that divide the ring into a plurality of sections. Each arch support as a vertex and the two arch supports are connected at their vertices. The domed arch is pivotally connected to a swivel. The swivel has two loops pivotally connected by a bolt.
Patent NZ-525474-A (NZ)
Title: Antiinflammation agents
Inventor: BROWNER MICHELLE F
IPC: C07D401/14
Filed: 2001-10-23
Abstract: Compounds of formula (I) which modulate the expression and/or function of proteins involved in inflammation, metabolism and cell proliferation and compositions containing these compounds are disclosed, wherein: W is N; X is CH; Y is O, S or N(R); and R, R1, R4, Z, A and B are as defined in the specification. These compounds and compositions containing them are useful in the treatment of inflammatory, immunoregulatory, metabolic and cell proliferative conditions or diseases.
Patent NZ-525917-A (NZ)
Title: Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists and their use in treating mGLuR5 receptor mediated disorders
Inventor: MUTEL VINCENT
IPC: C07D233/64
Filed: 2001-11-26
Abstract: Described is the use of compounds of Formula I in the manufacture of medicaments for the treatment or prevention of mGluR5 receptor mediated disorders such as neurological diseases wherein: R1, R2, R3, R4 and R5 are independently from each other, hydrogen, C1-C6- alkyl, -(CH2)n-halogen, C1-C6-alkoxy, -(CH2)n-NNR', -(CH2)n-N(R)-C(O)-(C1-C6)-alkyl, aryl or heteroaryl which is unsubstituted or substituted by one or more lower alkyl residues; R, R' and R" are independently from each other, hydrogen or C1-C6-alkyl; A is -CH=CH- or -C=C-; and B is compounds of formula B1)-B6) wherein: R6 is hydrogen, (C1-C6)-alkyl, -(CH2)n-C(O)OR, or halogen; R7 is hydrogen, (C1-C6)-alkyl, -(CH2)n-C(O)OR', halogen, nitro or heteroaryl which is unsubstituted or substituted by (C1-C6)-alkyl or cycloalkyl; R8 is hydrogen, (C1-C6)-alkyl, -(CH2)n-OH, -(CH2)n-C(O)OR" or aryl ; R9 is (C1-C6)-alkyl; R10 is hydrogen, C1-C6-alkyl or halogen; R11 is hydrogen or (C1-C6)-alkyl; R12 is -(CH2)n-N(R)-C(O)- (C1-C6)-alkyl; R13 is hydrogen or (C1-C6)alkyl; R14, R15, R16 and R17 are, independently from each other, hydrogen, (C1-C6)-alkyl, -(CH2)n-halogen or (C1-C6)-alkoxy; R18, R19 and R20 are, independently from each other, hydrogen, (C1-C6)-alkyl, -(CH2)n-halogen or (C1-C6)-alkoxy; R21 is hydrogen or lower alkyl; R22 is hydrogen, (C1-C6)-alkyl or (C1-C6)-alkyl carrying one or more substituents selected from hydroxy or halogen; R23 is hydrogen, (C1-C6)-alkyl, (C1-C6)-alkanoyl or nitro; R24, R25 and R26 are, independently from each other, hydrogen or (C1-C6)-alkyl; n is 0, 1, 2, 3, 4, 5 or 6; X is -CH2-, -O- or -S-; and Y is -CH= or -N=; and their pharmaceutically acceptable salts.
Patent NZ-526934-A (NZ)
Title: Stone simulating aggregate containing veneer systems
Inventor: EMESCHAJMER PIOTR
Filed: 2003-07-08
Abstract: Disclosed is a building panel with stone simulating veneer consisting of: a sheet, or sheet including substrate; and an adhesive system bonding to or into the surface of the sheet substrate allowing the bonding of a veneering sheet; and a preformed veneering sheet bonding to said adhesive system. Wherein said veneering sheet consists of: A substrate zone provided by a polymerized polymeric plastics binder system and stone pieces embedded by the binder system; and at least one continuous exterior zone of polymeric plastics material through which, as the outside face of the panel, some of the stone pieces behind the exterior zone can be seen. Also disclosed is a method of preforming said veneering sheet wherein: A polymeric system is layed up on a support surface Upon at least partial polymerization, over this polymeric system is layed up stone pieces and a polymeric plastics binder system. The resulting veneering sheet is removed from the support surface.
Patent NZ-528207-A (NZ)
Title: 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl) pyrazolo-[1,5-A]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands
Inventor: GILLIGAN PAUL J
IPC: A61P25/32
Filed: 2002-03-06
Abstract: Disclosed is the compound of formula (I), which is used for the manufacture of medicaments for antagonising a CRF receptor in a mammal, for treating such disorders such as anxiety or depression.